Gregor G.
- Country
- Sweden
- Department
- Njurmedicinska kliniken, Vita straket 12, 1 tr, Sahlgrenska universitetssjukhuset, 41345 Goteborg
Research Overview
- Stroke prophylaxis with Apixaban in Chronic Kidney Disease stage 5 patients with Atrial fibrillation (SACK)
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial of Povetacicept in Adults with Immunoglobulin A Nephropathy
- Evaluation of Aliskiren Versus Enalapril in the Management of C3 Glomerulopathy in Pediatric and Adult Populations
Data & Insights
Has run more than one trial at 58 of 396 partner sites.
Specializations
Glomerular Diseases
Specializes in investigating therapeutic approaches for C3 glomerulopathy and IgA nephropathy, focusing on novel treatments to address complement activation in the kidneys and reduce proteinuria.
- Complement-mediated renal diseases
- Renin inhibition therapy
- Immunoglobulin-related kidney disorders
Explores innovative therapeutic agents targeting specific pathways in glomerular diseases.
Chronic Kidney Disease
Conducts research on advanced chronic kidney disease treatments, with particular emphasis on patients with high proteinuria and those requiring specialized interventions.
- Proteinuria management
- CKD progression
- Novel therapeutic combinations
Investigates therapeutic approaches to slow kidney function decline and reduce albumin excretion.
Complex Renal Conditions
Focuses on treating patients with atrial fibrillation concurrent with severe kidney disease, exploring anticoagulation strategies and specialized therapeutic interventions.
- Stroke prevention in kidney disease
- Anticoagulation therapy
- Dialysis patient care
Evaluates safety and efficacy of treatments in complex renal patients with multiple comorbidities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.